PCNU in advanced adenocarcinoma of the ovary: a phase II study

Cancer Treat Rep. 1983 May;67(5):511-2.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Middle Aged
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Ovarian Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea